Following the publishing earlier this year of government emails urging for further research into the safety and effectiveness of CCSVI treatment to treat MS , the Canadian Government have approved a large scale investigation into CCSVI treatment, meaning that it could finally be recognized as the most effective approach to treating people with Multiple Sclerosis.
A new study, published in the Multiple Sclerosis Journal explores the link betwen the likelihood of developing progressive MS in relation to your age and gender. The average age of onset of MS is between 30 and 33 years old, with the average age of diagnosis being 37. Fewer than 10% of MS cases are diagnosed over the age of 50. The research aimed to see if the age of onset and diagnosis may give an indication of the likely course that the MS will take.
A new study looking at the association between breastfeeding in infancy and the development of MS has concluded that breastfeeding your baby could prevent them from developing MS in later life.
Multiple Sclerosis (MS) is an autoimmune disease which has acknowledged genetic and environmental triggers. Breastfeeding is known to boost the immune system of new-born babies and prevent a range of conditions, including some autoimmune diseases. This study was designed to look at the correlation between MS Sufferers and Non-MS Sufferers and their breast feeding history in infancy. Continue reading
The link between vitamin D and the onset of MS has been the subject of extensive research over the years. A review of all of these studies has shown that getting high levels of vitamin D, either through supplements or from sunlight, can prevent the onset of MS and even slow down the progression of the disease.